TEVA TEVA Company RSS Earnings Nov 10, 2026Teva Raises 2026 Outlook After Innovative Brands Reach $1.1 Billion Other Coverage September 28, 2026 QBook Stronger demand supports expansion as pricing diverges September 23, 2026 Drug Pipeline Abivax, Merck and Teva–Sanofi pursue the next wave of colitis therapies September 23, 2026 Drug Pipeline Teva and Sanofi take duvakitug into Phase 3 for ulcerative colitis
Stronger demand supports expansion as pricing diverges
Abivax, Merck and Teva–Sanofi pursue the next wave of colitis therapies